A Study of Severe Uterine Bleeding Following Exposure to Direct Oral Anticoagulants

NCT04394234 · clinicaltrials.gov ↗

COMPLETED

Status

961985

Enrollment

INDUSTRY

Sponsor class

Conditions

Uterine Hemorrhage

Interventions

DRUG: Direct oral anticoagulant (DOACs)
DRUG: Warfarin

Sponsor

Janssen Research & Development, LLC